Cognoa logo.

Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid

Cognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions (Palo Alto, Calif. – June 2nd, 2021) – Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced…

photo of Eric Mosbrooker COO

Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer

Mosbrooker will be leading the operational and commercial efforts of Cognoa’s digital behavioral health products (Palo Alto, Calif. – January 14, 2021) – Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health conditions, today announced the appointment of Eric B. Mosbrooker as Chief Operations Officer. Mosbrooker will be…

Cognoa logo.

Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study

Cognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism – a paradigm shift in the standard of care (Palo Alto, Calif. – September 23, 2020) – Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health conditions, announced today that…

Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer

Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries.  (Palo Alto, Calif. – March 24, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today the appointment of David Happel as Chief Executive Officer. Cognoa’s former CEO…

Cognoa Appoints Dr. Colleen Kraft Senior Medical Director of Clinical Adoption

AAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps (Palo Alto, Calif.– March 5, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that renowned pediatrician and 2018 Past President of the American Academy of Pediatrics (AAP), Dr. Colleen…

This shows a photo of Brent Vaughan CEO of Cognoa.

Cognoa CEO to Participate in the Cowen and Company 40th Annual Healthcare Conference

PALO ALTO, Calif. — February 26, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives from Akili Interactive Labs, Click Therapeutics and Pear Therapeutics. The panel will take place at 1:30…

Logo for Autism Learning Partners who Cognoa is partnered with.

Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care

PASADENA and PALO ALTO, Calif. – February 11, 2020 –  Autism Learning Partners (“ALP”), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to accelerate the diagnosis of autism to enable interventions earlier, when there is the greatest potential to…

Image announcing Brent Vaughan speaking at DTx West.

Cognoa Executives to Speak at DTx West 2020

PALO ALTO, Calif. — February 10, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on stage at the third annual DTx West 2020, taking place in San Mateo, California, February 18 to 20.   All events take place on the first day of the conference, Tuesday, February 18.…

Digital Health Global 100 Logo

Cognoa Named to the 2020 Global Digital Health 100 By The Journal of mHealth

International Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology Palo Alto, Calif., and London – January 29, 2020 –  Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, has been named to the 2020 Global Digital Health 100 list by The Journal of mHealth. Cognoa’s digital therapeutics will advance the standard of care by…

Cognoa logo.

Cognoa CEO and CMO Presenting at Digital Medicine & Medtech Showcase 2020 and Innovator MD Global Summit in San Francisco

PALO ALTO, Calif.- January 6, 2020—Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco. ● Brent Vaughan, CEO and co-founder of Cognoa, will provide an update on the company’s milestones and strategy at the Digital Medicine & Medtech Showcase™ 2020,…

Location

Social